Viewing Study NCT02215161

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 12:23 PM

Ignite Modification Date: 2025-12-27 @ 9:29 PM

Study NCT ID: NCT02215161

Status: TERMINATED

Last Update Posted: 2018-06-26

First Post: 2014-07-30

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Sponsor: University of California, San Francisco

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module